Q/C Technologies, Inc. Licenses Revenue (Deprecated 2018-01-31)
Q/C Technologies, Inc. (QCLS) reported Licenses Revenue (Deprecated 2018-01-31) of $305.56 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2017-04-11.
Discontinued › Income Statement › Other Income
us-gaap:LicensesRevenue · last filed 2017-04-11
- Q/C Technologies, Inc. licenses revenue (deprecated 2018-01-31) for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- Q/C Technologies, Inc. licenses revenue (deprecated 2018-01-31) for the quarter ending 2015-09-30 was $0.00, a 100.00% decline year-over-year.
- Q/C Technologies, Inc. licenses revenue (deprecated 2018-01-31) for the quarter ending 2015-06-30 was $212.22K, a 154.67% increase year-over-year.
- Q/C Technologies, Inc. licenses revenue (deprecated 2018-01-31) for the quarter ending 2015-03-31 was $83.33K, a 0.00% change year-over-year.
- Q/C Technologies, Inc. licenses revenue (deprecated 2018-01-31) for fiscal 2015 was $305.56K, a 8.33% decline from fiscal 2014.
- Q/C Technologies, Inc. licenses revenue (deprecated 2018-01-31) for fiscal 2014 was $333.33K, a 0.00% change from fiscal 2013.
- Q/C Technologies, Inc. licenses revenue (deprecated 2018-01-31) for fiscal 2013 was $333.33K.
| Period end | Licenses Revenue (Deprecated 2018-01-31) 3 month | Licenses Revenue (Deprecated 2018-01-31) 3 month as first filed | Licenses Revenue (Deprecated 2018-01-31) 6 month | Licenses Revenue (Deprecated 2018-01-31) 9 month | Licenses Revenue (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-11 | $0.00 derived: sum of 2 quarters · filed 2017-04-11 | $212.22K derived: sum of 3 quarters · filed 2017-04-11 | $305.56K 10-K · filed 2017-04-11 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $212.22K derived: sum of 2 quarters · filed 2016-11-14 | $305.56K 10-Q · filed 2016-11-14 | $378.89K derived: sum of 4 quarters · filed 2016-11-14 | |
| 2015-06-30 | $212.22K 10-Q · filed 2016-08-11 | $222.22K 10-Q · filed 2015-08-18 | $305.56K 10-Q · filed 2016-08-11 | $378.89K derived: sum of 3 quarters · filed 2016-08-11 | $462.22K derived: sum of 4 quarters · filed 2016-08-11 |
| 2015-03-31 | $83.33K 10-Q · filed 2016-05-12 | $166.67K derived: sum of 2 quarters · filed 2016-05-12 | $250.00K derived: sum of 3 quarters · filed 2016-05-12 | $333.33K derived: sum of 4 quarters · filed 2016-05-12 | |
| 2014-12-31 | $83.33K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $166.67K derived: sum of 2 quarters · filed 2016-03-30 | $250.00K derived: sum of 3 quarters · filed 2016-03-30 | $333.33K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $83.33K 10-Q · filed 2015-11-13 | $166.67K derived: sum of 2 quarters · filed 2015-11-13 | $250.00K 10-Q · filed 2015-11-13 | $333.33K derived: sum of 4 quarters · filed 2015-11-13 | |
| 2014-06-30 | $83.33K 10-Q · filed 2015-08-18 | $166.67K 10-Q · filed 2015-08-18 | $250.00K derived: sum of 3 quarters · filed 2015-08-18 | $333.33K derived: sum of 4 quarters · filed 2015-08-18 | |
| 2014-03-31 | $83.33K 10-Q · filed 2015-05-14 | $166.67K derived: sum of 2 quarters · filed 2015-05-14 | $250.00K derived: sum of 3 quarters · filed 2015-05-14 | $333.33K derived: sum of 4 quarters · filed 2015-05-14 | |
| 2013-12-31 | $83.33K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23 | $166.67K derived: sum of 2 quarters · filed 2015-03-23 | $250.00K derived: sum of 3 quarters · filed 2015-03-23 | $333.33K 10-K · filed 2015-03-23 | |
| 2013-09-30 | $83.33K 10-Q · filed 2014-11-13 | $166.67K derived: sum of 2 quarters · filed 2014-11-13 | $250.00K 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | $83.33K 10-Q · filed 2014-08-12 | $166.67K 10-Q · filed 2014-08-12 | |||
| 2013-03-31 | $83.33K 10-Q · filed 2014-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |